ULTRAGENYX PHARMACEUTICAL IN

Ticker: RARE CUSIP: 90400D108 Class: EQTY

Eagle Health Investments LP's Holding History (CIK: 0001842545)

Note: Option positions (PUT/CALL) are excluded.

Q3 2025

Shares 697,000 Value ($000) $20,966 Avg Close $29.99 Range $25.81 - $42.37

Q2 2025

Shares 627,600 Value ($000) $22,820 Avg Close $36.05 Range $29.59 - $40.19

Q1 2025

Shares 627,600 Value ($000) $22,725 Avg Close $41.60 Range $35.53 - $46.50

Q4 2024

Shares 627,600 Value ($000) $26,403 Avg Close $49.61 Range $41.26 - $57.99

Q3 2024

Shares 561,700 Value ($000) $31,202 Avg Close $50.94 Range $39.65 - $60.37

Q2 2024

Shares 524,500 Value ($000) $21,557 Avg Close $42.70 Range $37.02 - $52.56

Q1 2024

Shares 299,700 Value ($000) $13,993 Avg Close $47.17 Range $41.87 - $54.56

Period	Shares	Value ($000)	Average Close	Price Range
Q3 2025	697,000	$20,966	$29.99	$25.81 - $42.37
Q2 2025	627,600	$22,820	$36.05	$29.59 - $40.19
Q1 2025	627,600	$22,725	$41.60	$35.53 - $46.50
Q4 2024	627,600	$26,403	$49.61	$41.26 - $57.99
Q3 2024	561,700	$31,202	$50.94	$39.65 - $60.37
Q2 2024	524,500	$21,557	$42.70	$37.02 - $52.56
Q1 2024	299,700	$13,993	$47.17	$41.87 - $54.56